Market Place
Sourcing Support
FDA limits Merck`s Keytruda, BMS` Opdivo in Stomach Cancer
10 Jun 2025 //
FIERCE PHARMA
US FDA Approves Merck`s RSV Antibody for Infants
10 Jun 2025 //
REUTERS
Merck`s Cholesterol Drug Meets Main Goal in Two Studies
09 Jun 2025 //
REUTERS
Merck to Join 46th Annual Goldman Sachs Healthcare Conference
04 Jun 2025 //
BUSINESSWIRE
Merck made $3B offer for MoonLake & could revive interest
04 Jun 2025 //
FINANCIALTIMES
Arcus Kidney Cancer Drug Casdatifan Advances to Challenge Welireg
03 Jun 2025 //
BIOSPACE
Merck`s MK-1084 Shows Antitumor Activity in Phase 1 Trial
30 May 2025 //
BUSINESSWIRE
Merck takes middle dose of ROR ADC forward into phase 3
30 May 2025 //
BUSINESSWIRE
Patritumab Deruxtecan BLA Withdrawn for EGFR-Mutated Lung Cancer
29 May 2025 //
BUSINESSWIRE
Pimicotinib shows high efficacy in tenosynovial Giant Cell Tumor
29 May 2025 //
INDPHARMAPOST
Daiichi, Merck pull HER3-DXd filing at FDA
29 May 2025 //
REUTERS
Merck Announces Third-Quarter 2025 Dividend
27 May 2025 //
BUSINESSWIRE
Merck’s Ph2 Data For Enpatoran Shows SLE Rash Improvement
22 May 2025 //
INDPHARMAPOST
AZ, Merck Duke It out To Lead Oncologists’ Pharma Perceptions
22 May 2025 //
FIERCE PHARMA
Merck`s Biologics Keytruda Receives Suppl Approval in US
22 May 2025 //
FDA
Merck to Join Bernstein 41st Annual Strategic Decisions Conf.
22 May 2025 //
BUSINESSWIRE
Merck Showcases Innovation in Advanced Cancers and Rare Tumors
22 May 2025 //
BUSINESSWIRE
Antengene & MSD Enter into a Global Clinical Collaboration
21 May 2025 //
PR NEWSWIRE
Orion’s collaborator MSD expands Opevesostat for Women`s Cancers
21 May 2025 //
PRESS RELEASE
IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Begins
19 May 2025 //
BUSINESSWIRE
Merck to Share PAH Research at ATS 2025 Conference
16 May 2025 //
BUSINESSWIRE
Merck`s Phase 3 KEYNOTE-B96 Trial Meets Primary Endpoint
15 May 2025 //
BUSINESSWIRE
FDA expands use of Merck`s cancer drug for adrenal gland tumors
15 May 2025 //
REUTERS
FDA Approves Merck’s Welireg for Rare PPGL Tumor Treatment
14 May 2025 //
BUSINESSWIRE
Merck to Present Oncology Advances at ASCO 2025
13 May 2025 //
BUSINESSWIRE
Merck Animal Health, Kansas to Invest $895M in De Soto Facilities
08 May 2025 //
BUSINESSWIRE
Merck to Join Bank of America 2025 Healthcare Conference
07 May 2025 //
BUSINESSWIRE
Dawn Health, Merck Launch Digital Ecosystem for Growth Disorders
07 May 2025 //
PR NEWSWIRE
AmacaThera, Merck Animal Health Collaborate in Animal Health
01 May 2025 //
PR NEWSWIRE
Merck starts $1 billion Biologics Center in Delaware, US
30 Apr 2025 //
PRESS RELEASE
Keytruda improves survival in head and neck Cancer
27 Apr 2025 //
BUSINESSWIRE
Halozyme sues Merck over subcutaneous Keytruda
25 Apr 2025 //
PRESS RELEASE
Merck CEO talks strategy amid tariff, policy uncertainty
24 Apr 2025 //
FIERCE PHARMA
Merck Announces First-Quarter 2025 Financial Results
24 Apr 2025 //
BUSINESSWIRE
Nissan Chemical extends supply deal with MSD Animal Health
16 Apr 2025 //
INDPHARMAPOST
Cyprumed partners with MSD for oral peptide therapeutics
15 Apr 2025 //
GLOBENEWSWIRE
Merck Ceo Rob Davis` 2024 Pay Climbed 13% To $23.2M
14 Apr 2025 //
FIERCE PHARMA
Merck Manuals to Power Microsoft Copilot Health Agent
14 Apr 2025 //
PR NEWSWIRE
Merck to Hold Q1 2025 Sales and Earnings Call on April 24
01 Apr 2025 //
BUSINESSWIRE
Merck`s Winrevair cuts death, morbidity risk by 76%
01 Apr 2025 //
FIERCE PHARMA
Merck Exercised Option for Global Rights of Abbisko`s Pimicotinib
31 Mar 2025 //
PR NEWSWIRE
Merck plans to launch US subcutaneous version of Keytruda
28 Mar 2025 //
REUTERS
Merck, Zebra Partner On Safety & Traceability Solutions
27 Mar 2025 //
INDPHARMAPOST
EMA approves Merck`s Capvaxive for invasive pneumococcal disease
27 Mar 2025 //
INDPHARMAPOST
Merck Commits Nearly $2B for Oral Lipid-Lowering Drug from Chinese Biotech
26 Mar 2025 //
BIOSPACE
First Patient Dosed In Immutep’s Ph III NSCLC Trial
25 Mar 2025 //
GLOBENEWSWIRE
Merck Data at ACC.25 Showcases Advancements in Cardiovascular
19 Mar 2025 //
BUSINESSWIRE
Merck`s Biologic Keytruda Receives Approval in US
19 Mar 2025 //
FDA
Merck: Positive Phase 3 Data on Doravirine/Islatravir HIV Regimen
12 Mar 2025 //
BUSINESSWIRE
Merck opens $1B Gardasil manufacturing facility in North Carolina
12 Mar 2025 //
BUSINESSWIRE
Merck prevails in US safety litigation over Gardasil HPV vaccine
11 Mar 2025 //
REUTERS
Merck’s Injectable Keytruda Create Legal Dispute With Halozyme
06 Mar 2025 //
BIOSPACE
IO Biotech Reports 2024 Business Highlights
04 Mar 2025 //
GLOBENEWSWIRE
Merck nabs $30M from Delaware for potential facility
01 Mar 2025 //
FIERCE PHARMA
Merck expects Keytruda to be part of government price
26 Feb 2025 //
REUTERS
Medicenna Reports MDNA11’s Anti-Cancer Activity at AACR Conference
25 Feb 2025 //
GLOBENEWSWIRE
FDA Grants Review To Merck’s Keytruda Combo For Head & Neck Cancer
25 Feb 2025 //
BUSINESSWIRE
Merck to Participate in the TD Cowen Annual Health Care Conference
24 Feb 2025 //
BUSINESSWIRE
Merck Plans Workforce Expansion in India
23 Feb 2025 //
ECONOMICTIMES
Merck’s Welireg receives European approval for two indications
20 Feb 2025 //
PRESS RELEASE
